BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases

Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=67208f6ba8d4496c8fc9d2ddee6db7e3&url=https%3A%2F%2Fwww.pharmiweb.com%2Fpress-release%2F2024-10-29%2Fbionxt-announces-national-level-patent-filings-for-sublingual-anticancer-drugs-for-the-treatment-of&c=15055478714527082713&mkt=de-de

Author :

Publish date : 2024-10-29 00:31:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version